Stryker (SYK) Cyberattack Puts Its Undervalued Narrative To The Test

Simply Wall St.07-16 22:31

Stryker (SYK) is under scrutiny after a cyberattack linked to Iranian hackers triggered factory resets on over 200,000 medical devices worldwide, temporarily halting order processing and production in...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2651423219?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/94614-main-header/1756253509683","is_english":true,"pubTime":"2026-07-16 22:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2651423219","market":"us","top_or_hot":-1,"title":"Stryker (SYK) Cyberattack Puts Its Undervalued Narrative To The Test","media":"Simply Wall St.","content":"<div>\n<p>Stryker (SYK) is under scrutiny after a cyberattack linked to Iranian hackers triggered factory resets on over 200,000 medical devices worldwide, temporarily halting order processing and production in...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-syk/stryker/news/stryker-syk-cyberattack-puts-its-undervalued-narrative-to-th\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stryker (SYK) Cyberattack Puts Its Undervalued Narrative To The Test</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStryker (SYK) Cyberattack Puts Its Undervalued Narrative To The Test\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-16 22:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-syk/stryker/news/stryker-syk-cyberattack-puts-its-undervalued-narrative-to-th><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stryker (SYK) is under scrutiny after a cyberattack linked to Iranian hackers triggered factory resets on over 200,000 medical devices worldwide, temporarily halting order processing and production in...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-syk/stryker/news/stryker-syk-cyberattack-puts-its-undervalued-narrative-to-th\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2506951875.HKD","symbol_name":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-syk/stryker/news/stryker-syk-cyberattack-puts-its-undervalued-narrative-to-th","article_id":"2651423219","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/94614-main-header/1756253509683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-syk/stryker/news/stryker-syk-cyberattack-puts-its-undervalued-narrative-to-th","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2651423219","pubTimestamp":1784212297,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Stryker (SYK) is under scrutiny after a cyberattack linked to Iranian hackers triggered factory resets on over 200,000 medical devices worldwide, temporarily halting order processing and production in dozens of countries.\nSee our latest analysis for Stryker.\nAt a share price of $316.44, Stryker has seen its 1 day share price return rise 1.73%, but the year to date share price return is down 9.12% and the 1 year total shareholder return has declined 18.22%. This suggests recent concerns around...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2506951875.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) ACC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A","LU0690374615.EUR":"FUNDSMITH EQUITY \"R\" (EUR) ACC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU2506952097.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) ACC","BK4566":"资本集团","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU0823417737.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU2506951958.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) INC","SYK":"史赛克","BK4082":"医疗保健设备","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU0950375773.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC A","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","BK4504":"桥水持仓","LU0528227936.USD":"富达环球人口趋势基金A-ACC","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU2506952170.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) INC","IHI":"iShares Dow Jones U.S. Medical D","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","BK4588":"碎股","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU0823417653.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) ACC","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","GB00B4QBRK32.GBP":"FUNDSMITH EQUITY \"R\" (GBP) INC","GB00B4LPDJ14.GBP":"FUNDSMITH EQUITY \"R\" (GBP) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","LU2404859741.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) INC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU2404859667.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) ACC","BK4585":"ETF&股票定投概念","LU0690374961.EUR":"FUNDSMITH EQUITY \"R\" (EUR) INC"},"translate_title":"史赛克 (SYK) 网络攻击考验其被低估的叙述","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYK":1.5,"IHI":0.6},"content_text":"Stryker (SYK) is under scrutiny after a cyberattack linked to Iranian hackers triggered factory resets on over 200,000 medical devices worldwide, temporarily halting order processing and production in dozens of countries. See our latest analysis for Stryker. At a share price of $316.44, Stryker has seen its 1 day share price return rise 1.73%, but the year to date share price return is down 9.12% and the 1 year total shareholder return has declined 18.22%. This suggests recent concerns around the cyberattack and softer capital equipment spending are weighing more heavily than the company’s longer term 3 year and 5 year total shareholder returns of 10.65% and 28.85%. If this cybersecurity shock has you reassessing where growth and risk sit in your portfolio, it could be worth scanning for other healthcare technology stories through the 40 healthcare AI stocks. Bulls argue Stryker’s scale and growth track record outweigh a one off cyber shock, while bears see a richly priced stock exposed to weaker hospital budgets and rising competition. Which side does the valuation actually support next? AdvertisementMost Popular Narrative: 18% Undervalued Stryker is trading at $316.44 compared with a widely followed fair value narrative of $386.80. This frames the current pullback as a valuation gap rather than a broken story.  Robust innovation pipeline, particularly in robotic-assisted surgery (Mako platform) and next-generation devices, is driving greater market share, higher average selling prices, and service revenues, which is expected to accelerate both revenue and margin expansion over time.  Read the complete narrative. Read the complete narrative. Want to see what sits behind that confidence in Stryker? The narrative leans on steady revenue compounding, rising margins, and a future earnings base that has to clear a high bar. The exact hurdle rates, growth path, and profit assumptions are where the story really gets interesting. Result: Fair Value of $386.80 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, that underpriced story for Stryker also depends on smooth execution, and prolonged regulatory delays or sustained supply chain disruption could quickly challenge those assumptions. Find out about the key risks to this Stryker narrative. Another View: Stryker Looks Expensive On P/E While the SWS DCF model suggests Stryker is trading at a discount to its estimated future cash flow value of $400.68, the P/E picture is less forgiving. At 36.4x, the stock trades above the US Medical Equipment industry on 26.1x, peers on 27.6x, and even its own 34.3x fair ratio; this points to valuation risk if growth or margins fall short. Put simply, the DCF flags upside if Stryker delivers on its long term forecasts, but the rich earnings multiple leaves less room for disappointment. Which lens do you rely on more when sizing your position? See what the numbers say about this price — find out in our valuation breakdown. NYSE:SYK P/E Ratio as at Jul 2026Next Steps Seeing both optimism and concern around Stryker in this article, it makes sense to move quickly, weigh the data for yourself, and review the 4 key rewards and 2 important warning signs Looking for more investment ideas beyond Stryker? If Stryker has sharpened your focus on quality and risk, do not stop here. Broaden your watchlist now with targeted stock ideas built from hard data.  Target long term value potential by scanning companies that look mispriced on fundamentals using the 47 high quality undervalued stocks. Strengthen your income stream by reviewing stocks with resilient cash flows in the 10 dividend fortresses. Dial down portfolio risk by filtering for sturdier businesses and balance sheets through the 78 resilient stocks with low risk scores.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2651423219","isCrawlerRequest":true}